BG
MJN

Bahl & Gaynor’s Mead Johnson Nutrition Company MJN Stock Holding History

Bahl & Gaynor’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,187
Closed -$296K – 399
2016
Q4 		$296K Sell
4,187
-11,654
-74% -$869K ﹤0.01% 356
2016
Q3 		$1.25M Buy
15,841
+424
+3% +$36.2K 0.02% 213
2016
Q2 		$1.4M Sell
15,417
-13
-0.1% -$1.1K 0.02% 195
2016
Q1 		$1.31M Buy
15,430
+1,513
+11% +$113K 0.02% 200
2015
Q4 		$1.1M Buy
13,917
+2,513
+22% +$198K 0.02% 218
2015
Q3 		$803K Buy
11,404
+7,819
+218% +$643K 0.01% 253
2015
Q2 		$323K Hold
3,585
– – ﹤0.01% 376
2015
Q1 		$360K Buy
3,585
+50
+1% +$5.04K ﹤0.01% 351
2014
Q4 		$355K Sell
3,535
-20
-0.6% -$1.99K 0.01% 340
2014
Q3 		$342K Hold
3,555
– – 0.01% 342
2014
Q2 		$331K Hold
3,555
– – 0.01% 332
2014
Q1 		$296K Sell
3,555
-30
-0.8% -$2.43K ﹤0.01% 341
2013
Q4 		$300K Hold
3,585
– – ﹤0.01% 334
2013
Q3 		$266K Hold
3,585
– – ﹤0.01% 331
2013
Q2 		$284K Buy
+3,585
New +$287K 0.01% 316

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bahl & Gaynor's MJN Position: Q1 2017 in Review

Bahl & Gaynor sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 4,187 shares — an estimated $296K sold.

Bahl & Gaynor first reported a position in MJN in Q2 2013 and held it in 15 quarters. The position peaked at $1.4M in Q2 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Bahl & Gaynor reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Bahl & Gaynor sold 4,187 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $296K.
  • Bahl & Gaynor first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 15 quarters.
  • Bahl & Gaynor's Mead Johnson Nutrition Company position peaked at $1.4M in Q2 2016.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Bahl & Gaynor's 13F filing for Q1 2017, filed 9 May 2017.